Trials / Unknown
UnknownNCT02988141
EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC
A Prospective Multi-center Study to Investigate the EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Jianxing He · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Prospective Multi-center Study to Investigate the EGFR-TKI Resistance Profile in Chinese Patients with Advanced EGFRm+ NSCLC
Detailed description
Patients with EGFR mutation and presented secondary resistance to prior first-generation EGFR-TKI should have received biopsy of at least on progressed lesions and are able to provide tissues for pathological examination and NGS testing.All enrolled patients will be followed up to clinical outcome (treatments, tumor response, survival, etc).
Conditions
Timeline
- Start date
- 2017-03-01
- Primary completion
- 2020-12-01
- Completion
- 2021-02-01
- First posted
- 2016-12-09
- Last updated
- 2017-01-20
Source: ClinicalTrials.gov record NCT02988141. Inclusion in this directory is not an endorsement.